Replies to post #351 on Cempra, Inc. (CEMP)

[Johnny_C]

That will not happen. They are to small, don't have any leverage and must have done something to really tick the FDA off. The FDA previously fast tracked company. My guess is she was stating things that the FDA accepted in conferences and they were not true.

When safety is involved, all testing of the drug is evaluated not just limited trials.

Very unfortunate, From 40 to 3 in the blink of an eye, or it seemed.

[Johnny_C]

A buyout for 10 or more would be a win right now, I think.